Brain, Vol. 106, No. 3, 761-775, 1983
© 1983 Guarantors of Brain
research-article |
CEREBRAL GLUCOSE UTILIZATION, AS MEASURED WITH POSITRON EMISSION TOMOGRAPHY IN 21 RESTING HEALTHY MEN BETWEEN THE AGES OF 21 AND 83 YEARS
1 From the Section on Brain Aging and Dementia, Laboratory of Neurosciences, National Institute on Aging, Clinical Center 2 Laboratory of Cerebral Metabolism Bethesda; MD 20205, USA 3 Laboratory of Psychology and Psychopathology, National Institute of Mental Health Bethesda; MD 20205, USA 4 Department of Nuclear Medicine, Clinical Center, National Institutes of Health Bethesda; MD 20205, USA
Positron emission tomography (PET) scanning with 18F-2-deoxy-D-glucose was employed to examine hemispheric and regional rates of cerebral glucose utilization in 21 resting healthy men between the ages of 21 and 83 years. The eyes of the subjects were covered and the external auditory canals were plugged with cotton in the 45 minutes following injection of tracer. Mean hemispheric cerebral metabolic rates for glucose (CMRglc) averaged 4.3 to 4.4 mg. 100 g–1. min–1, and mean hemispheric grey matter glucose utilization, (CMRglc)grey, averaged 5.2 to 5.3 mg. 100 g–1. min–1. Neither parameter was correlated significantly with age, nor were their right/left ratios correlated with age (P > 0.05). The mean ratios, furthermore, did not differ significantly from 1. Regional cerebral metabolic rates for glucose, rCMRglc, at each of 31 identified midline and bilateral structures also were not correlated significantly with age. Mean rCMRglc ranged from 2.6 mg. 100 g–1. min–1 at the centrum semiovale to 6.2 mg. 100 g–1. min–1 at the precentral gyrus of the frontal lobe and precuneus of the parietal lobe. The results indicate that the cerebral metabolic rate for glucose is not correlated with age in healthy men.
Received July 13, 1982.
Revised January 27, 1983.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  W.-D. Heiss, B. Habedank, J. C. Klein, K. Herholz, K. Wienhard, M. Lenox, and R. Nutt Metabolic Rates in Small Brain Nuclei Determined by High-Resolution PET J. Nucl. Med., November 1, 2004; 45(11): 1811 - 1815. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. J. Teipel, G. E. Alexander, M. B. Schapiro, H.-J. Moller, S. I. Rapoport, and H. Hampel Age-related cortical grey matter reductions in non-demented Down's syndrome adults determined by MRI with voxel-based morphometry Brain, April 1, 2004; 127(4): 811 - 824. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. S. Krasuski, G. E. Alexander, B. Horwitz, S. I. Rapoport, and M. B. Schapiro Relation of Medial Temporal Lobe Volumes to Age and Memory Function in Nondemented Adults With Down's Syndrome: Implications for the Prodromal Phase of Alzheimer's Disease Am J Psychiatry, January 1, 2002; 159(1): 74 - 81. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Fazio and D. Perani Importance of Partial-Volume Correction in Brain PET Studies J. Nucl. Med., November 1, 2000; 41(11): 1849 - 1850. [Full Text] [PDF]
|
|
|
|
 |
|
 L. T. Kwan, B. R. Reed, J. L. Eberling, N. Schuff, J. Tanabe, D. Norman, M. W. Weiner, and W. J. Jagust Effects of Subcortical Cerebral Infarction on Cortical Glucose Metabolism and Cognitive Function Arch Neurol, July 1, 1999; 56(7): 809 - 814. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Esposito, B. S. Kirkby, J. D. Van Horn, T. M. Ellmore, and K. F. Berman Context-dependent, neural system-specific neurophysiological concomitants of ageing: mapping PET correlates during cognitive activation Brain, May 1, 1999; 122(5): 963 - 979. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B.-w. Soong and R.-s. Liu Positron emission tomography in asymptomatic gene carriers of Machado-Joseph disease J. Neurol. Neurosurg. Psychiatry, April 1, 1998; 64(4): 499 - 504. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S Lamusuo, H M Ruottinen, J Knuuti, R Harkonen, U Ruotsalainen, J Bergman, M Haaparanta, O Solin, E Mervaala, U Nousiainen, et al. Comparison of[18F]FDG-PET, [99mTc]-HMPAO-SPECT, and [123I]-iomazenil-SPECT in localising the epileptogenic cortex J. Neurol. Neurosurg. Psychiatry, December 1, 1997; 63(6): 743 - 748. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. G. M. Murphy, P. A. Bottomley, J. A. Salerno, C. DeCarli, M. J. Mentis, C. L. Grady, D. Teichberg, K. R. Giacometti, J. M. Rosenberg, C. J. Hardy, et al. An In Vivo Study of Phosphorus and Glucose Metabolism in Alzheimer's Disease Using Magnetic Resonance Spectroscopy and PET Arch Gen Psychiatry, May 1, 1993; 50(5): 341 - 349. [Abstract] [PDF]
|
|
|
|
|
|
D. G. M. Murphy, C. DeCarli, M. B. Schapiro, S. I. Rapoport, and B. Horwitz Age-Related Differences in Volumes of Subcortical Nuclei, Brain Matter, and Cerebrospinal Fluid in Healthy Men as Measured With Magnetic Resonance Imaging Arch Neurol, August 1, 1992; 49(8): 839 - 845. [Abstract] [PDF]
|
|
|
|
|
|
J. M. Hoffman, J. C. Mazziotta, T. C. Hawk, and R. Sumida Cerebral Glucose Utilization in Motor Neuron Disease Arch Neurol, August 1, 1992; 49(8): 849 - 854. [Abstract] [PDF]
|
|
|
|
|
|
M. B. Schapiro, J. R. Atack, I. Hanin, C. May, J. V. Haxby, and S. I. Rapoport Lumbar Cerebrospinal Fluid Choline in Healthy Aging and in Down's Syndrome Arch Neurol, September 1, 1990; 47(9): 977 - 980. [Abstract] [PDF]
|
|
|
|
|
|
J. V. Haxby, C. L. Grady, E. Koss, B. Horwitz, L. Heston, M. Schapiro, R. P. Friedland, and S. I. Rapoport Longitudinal Study of Cerebral Metabolic Asymmetries and Associated Neuropsychological Patterns in Early Dementia of the Alzheimer Type Arch Neurol, July 1, 1990; 47(7): 753 - 760. [Abstract] [PDF]
|
|
|
|
|
|
O. Devinsky, S. Sato, R. A. Conwit, and M. B. Schapiro Relation of EEG Alpha Background to Cognitive Function, Brain Atrophy, and Cerebral Metabolism in Down's Syndrome: Age-Specific Changes Arch Neurol, January 1, 1990; 47(1): 58 - 62. [Abstract] [PDF]
|
|
|
|
|
|
S. E. Swedo, M. B. Schapiro, C. L. Grady, D. L. Cheslow, H. L. Leonard, A. Kumar, R. Friedland, S. I. Rapoport, and J. L. Rapoport Cerebral Glucose Metabolism in Childhood-Onset Obsessive-Compulsive Disorder Arch Gen Psychiatry, June 1, 1989; 46(6): 518 - 523. [Abstract] [PDF]
|
|
|
|
|
|
C. L. Grady, A. M. Grimes, N. Patronas, T. Sunderland, N. L. Foster, and S. I. Rapoport Divided Attention, as Measured by Dichotic Speech Performance, in Dementia of the Alzheimer Type Arch Neurol, March 1, 1989; 46(3): 317 - 320. [Abstract] [PDF]
|
|
|
|
|
|
D. A. Loewenstein, W. W. Barker, J.-Y. Chang, A. Apicella, F. Yoshii, P. Kothari, B. Levin, and R. Duara Predominant Left Hemisphere Metabolic Dysfunction in Dementia Arch Neurol, February 1, 1989; 46(2): 146 - 152. [Abstract] [PDF]
|
|
|
|
|
|
I. Rainero, J. A. Kaye, C. May, R. Durso, D. I. Katz, M. L. Albert, N. Wolfe, L. Pinessi, R. P. Friedland, and S. I. Rapoport {alpha}-Melanocyte-Stimulating Hormonelike Immunoreactivity Is Increased in Cerebrospinal Fluid of Patients With Parkinson's Disease Arch Neurol, November 1, 1988; 45(11): 1224 - 1227. [Abstract] [PDF]
|
|
|
|
|
|
B. Horwitz, J. M. Rumsey, C. L. Grady, and S. I. Rapoport The Cerebral Metabolic Landscape in Autism: Intercorrelations of Regional Glucose Utilization Arch Neurol, July 1, 1988; 45(7): 749 - 755. [Abstract] [PDF]
|
|
|
|
|
|
J. R. Atack, M. F. Beal, C. May, J. A. Kaye, M. F. Mazurek, A. D. Kay, and S. I. Rapoport Cerebrospinal Fluid Somatostatin and Neuropeptide Y: Concentrations in Aging and in Dementia of the Alzheimer Type With and Without Extrapyramidal Signs Arch Neurol, March 1, 1988; 45(3): 269 - 274. [Abstract] [PDF]
|
|
|
|
|
|
G. P. Rodgers, C. M. Clark, S. M. Larson, S. I. Rapoport, A. W. Nienhuis, and A. N. Schechter Brain Glucose Metabolism in Neurologically Normal Patients With Sickle Cell Disease: Regional Alterations Arch Neurol, January 1, 1988; 45(1): 78 - 82. [Abstract] [PDF]
|
|
|
|
 |
|
 G. Berg, C. L. Grady, M. Sundaram, J. V. Haxby, A. M. Moore, J. White, L. Heston, S. I. Rapoport, and L. V. Avioli Positron Emission Tomography in Dementia of the Alzheimer Type: A Brief Review With a Case Study Arch Intern Med, October 1, 1986; 146(10): 2045 - 2049. [Abstract] [PDF]
|
|
|
|
|
|
J. V. Haxby, C. L. Grady, R. Duara, N. Schlageter, G. Berg, and S. I. Rapoport Neocortical Metabolic Abnormalities Precede Nonmemory Cognitive Defects in Early Alzheimer's-Type Dementia Arch Neurol, September 1, 1986; 43(9): 882 - 885. [Abstract] [PDF]
|
|
|
|
|
|
H. Creasey, J. M. Rumsey, M. Schwartz, R. Duara, J. L. Rapoport, and S. I. Rapoport Brain Morphometry in Autistic Men as Measured by Volumetric Computed Tomography Arch Neurol, July 1, 1986; 43(7): 669 - 672. [Abstract] [PDF]
|
|
|
|
 |
|
 N. R. Cutler and P. K. Narang Alzheimer's disease: clinical, neuropathologic, neuropsychologic, and brain metabolic findings American Journal of Alzheimer's Disease and Other Dementias, January 1, 1986; 1(1): 16 - 23. [Abstract] [PDF]
|
|
|
|
 |
|
 N. R. CUTLER, L. L. HESTON, P. DAVIES, J. V. HAXBY, and M. B. SCHAPIRO Alzheimer's Disease and Down's Syndrome: New Insights Ann Intern Med, October 1, 1985; 103(4): 566 - 578. [Abstract] [PDF]
|
|
|
|
|
|
J. M. Rumsey, R. Duara, C. Grady, J. L. Rapoport, R. A. Margolin, S. I. Rapoport, and N. R. Cutler Brain Metabolism in Autism: Resting Cerebral Glucose Utilization Rates as Measured With Positron Emission Tomography Arch Gen Psychiatry, May 1, 1985; 42(5): 448 - 455. [Abstract] [PDF]
|
|
|
|
 |
|
 D. Wong, H. Wagner Jr, R. Dannals, J. Links, J. Frost, H. Ravert, A. Wilson, A. Rosenbaum, A Gjedde, K. Douglass, et al. Effects of age on dopamine and serotonin receptors measured by positron tomography in the living human brain Science, December 21, 1984; 226(4681): 1393 - 1396. [Abstract] [PDF]
|
|
|
|
|
|
N. R. CUTLER, R. DUARA, H. CREASEY, C. L. GRADY, J. V. HAXBY, M. B. SCHAPIRO, and S. I. RAPOPORT Brain Imaging: Aging and Dementia Ann Intern Med, September 1, 1984; 101(3): 355 - 369. [Abstract] [PDF]
|
|